Medication info
Wonttran Sustained Release Tablet

Wonttran Sustained Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›75mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Light yellow rectangular film-coated sustained release tablet
Packaging
For domestic use: 30 tablets/bottle, 100 tablets/bottle For export: 30 tablets (10 tablets/PTP x 3), 100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 201207592 · Approved 2012.10.31 · Insurance code 671805340

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended. Thereafter, doses should be taken at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; therefore, monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used for the relief of moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and treatment response. An initial dose of 1 tablet is recommended. Thereafter, doses should be taken at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, drowsiness, etc. may occur when taking this medicine; therefore, monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine in patients with renal impairment have not been established; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine in patients with hepatic impairment have not been established; therefore, its use is not recommended.

Precautions

This medicine may cause liver damage in those who regularly consume more than three glasses of alcohol daily, so consultation with a doctor or pharmacist is essential. If a rash or other allergic reactions appear on the skin while taking this medication, discontinue use immediately and inform your doctor. Due to the presence of tramadol, exceeding the recommended dose may increase the risk of seizures, especially when taken with certain antidepressants or other narcotics. Rarely, severe allergic reactions may occur when taking this medicine, and patients should inform medical personnel immediately if symptoms develop. Patients with acute and severe bronchial asthma may be at risk for respiratory depression when taking this medicine and should only be administered in an environment equipped for cardiopulmonary resuscitation. Caution should be exercised when taking this medicine with alcohol or benzodiazepines, as it may cause severe sedation, respiratory depression, or coma. Patients with head injuries or brain diseases need to be cautious as respiratory depression may worsen symptoms when taking this medicine. This medication may cause dependence similar to morphine; therefore, careful observation for dependence and potential abuse is required with long-term use. Patients with impaired liver function should consult a doctor before taking this medicine and avoid taking it alongside other products containing acetaminophen. Patients with certain genotypes may have accelerated metabolism of this medication, increasing the risk of respiratory depression, and dosage adjustment or alternative medications may need to be considered in these cases. This medication is not recommended for children under 12 years or adolescents under 18 years who have undergone tonsillectomy and adenoidectomy. Elderly patients should be closely monitored as they may have decreased liver, kidney, or heart function when using this medication. Women who are pregnant or might become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding women are recommended not to use it. Drowsiness or dizziness may occur while taking this medication, so caution is needed when driving or operating machinery. Overdose can lead to serious side effects such as respiratory depression and liver damage, so the recommended dose must be adhered to, and immediate emergency treatment should be sought if overdose is suspected. This medication may interact with various drugs, so patients must inform medical personnel if they are taking other medications and be especially cautious when taken with central nervous system depressants or antidepressants.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, increased tension, migraine, worsening of migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, irritability, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thinking, anemia, dyspnea, proteinuria, urination disorders, oliguria, urine retention, pruritus, rash, sweating, urticaria, liver dysfunction, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, muscle weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, serotonin syndrome, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, high anion gap metabolic acidosis, leukocytosis, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory disturbance, lethargy, taste disturbance, involuntary muscle contractions, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, blood pressure elevation, palpitations, irregular menstruation, breast cancer, injury, congestive heart failure, dizziness, confusion, exertional dyspnea, bronchitis, frequent urination, abnormal kidney function tests, palpitations, aortic stenosis, rectal bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, cholangiocarcinoma progression, foreign body sensation in the eye, liver cancer progression, cholecystitis, paralytic ileus, hiccups, increased salivation, colorectal cancer progression, esophageal cancer progression, gastric cancer progression, drowsiness, emotional instability, thrombocytopenia, leukopenia, leukocytosis, hemoglobin decrease, recurrence of myocardial infarction, loss of consciousness, hypotension, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, back pain, musculoskeletal pain, neck pain, side pain, upper respiratory infection, pneumonia, memory impairment, gastrointestinal disorders, lack of efficacy, spatial disorientation, facial flushing, heartburn, acute gastritis, cold, motion sickness, lethargy, weakness, fever, edema, rigidity, syncope, withdrawal symptoms, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, sensory abnormalities, tinnitus, abnormal central nervous system reactions, opioid dependence, withdrawal symptoms, opioid-induced hyperalgesia, adrenal insufficiency, paralytic ileus, cholecystitis, abnormal kidney function tests, rectal bleeding

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medicine in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Light yellow rectangular film-coated sustained release tablet

Package unit

For domestic use: 30 tablets/bottle, 100 tablets/bottle For export: 30 tablets (10 tablets/PTP x 3), 100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.